114 related articles for article (PubMed ID: 18613433)
1. Survival rate of pancreatic cancer in elderly patients.
Wang P; Meng ZQ; Chen Z; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Zhu ZF; Zhao GF; Fu H; Liu LM
Hepatogastroenterology; 2008; 55(82-83):681-6. PubMed ID: 18613433
[TBL] [Abstract][Full Text] [Related]
2. [Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].
Wang Y; Zhao P; Wang CF; Shan Y; Zhao DB; Tian YT; Sun YM; Che X; Zhang JW
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2381-5. PubMed ID: 20137689
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for long-term survival in patients with locally invasive pancreatic cancer.
Tani M; Kawai M; Terasawa H; Ina S; Hirono S; Shimamoto T; Miyazawa M; Uchiyama K; Yamaue H
J Hepatobiliary Pancreat Surg; 2007; 14(6):545-50. PubMed ID: 18040618
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials.
Cubiella J; Castells A; Fondevila C; Sans M; Sabater L; Navarro S; Fernández-Cruz L
Am J Gastroenterol; 1999 May; 94(5):1271-8. PubMed ID: 10235206
[TBL] [Abstract][Full Text] [Related]
5. Predictors of systemic chemotherapy contraindication in pancreatic cancer patients with distant metastasis.
Zhang Y; Dang C; Ma Q; Chen W; Nagata K
Hepatogastroenterology; 2007; 54(73):254-9. PubMed ID: 17419272
[TBL] [Abstract][Full Text] [Related]
6. Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer.
Xiong LL; Hwang JH; Huang XB; Yao SS; He CJ; Ge XH; Ge HY; Wang XF
JOP; 2009 Mar; 10(2):123-9. PubMed ID: 19287104
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
8. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
[TBL] [Abstract][Full Text] [Related]
10. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 2340 cases of pancreatic cancer].
Zhang QH; Ni QX;
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):214-8. PubMed ID: 15059537
[TBL] [Abstract][Full Text] [Related]
12. Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment.
Aparicio T; Navazesh A; Boutron I; Bouarioua N; Chosidow D; Mion M; Choudat L; Sobhani I; Mentré F; Soulé JC
Crit Rev Oncol Hematol; 2009 Sep; 71(3):249-57. PubMed ID: 19131256
[TBL] [Abstract][Full Text] [Related]
13. [Surgery for pancreatic cancer].
Welsch T; Büchler MW; Schmidt J
Z Gastroenterol; 2008 Dec; 46(12):1393-403. PubMed ID: 19053009
[TBL] [Abstract][Full Text] [Related]
14. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
15. Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?
Cheung MC; Yang R; Byrne MM; Solorzano CC; Nakeeb A; Koniaris LG
Cancer; 2010 Feb; 116(3):723-33. PubMed ID: 19998350
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors.
Jiang R; Tang J; Cheng X; Zang RY
Eur J Surg Oncol; 2009 Jan; 35(1):92-7. PubMed ID: 18632244
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and unresectable pancreatic cancer.
Yoo T; Lee WJ; Woo SM; Kim TH; Han SS; Park SJ; Moon SH; Shin KH; Kim SS; Hong EK; Kim DY; Park JW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e623-30. PubMed ID: 21600705
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
20. CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy.
Koom WS; Seong J; Kim YB; Pyun HO; Song SY
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1148-54. PubMed ID: 18760544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
